LY2181308 sodium

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Acute Myeloid LeukemiaProstate Cancer

Phase 2

A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

CompletedNCT00620321

Eli Lilly and CompanyAcute Myeloid Leukemia

Start: 2008-03-31End: 2010-01-31Updated: 2019-09-09

A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer

CompletedNCT00642018

Eli Lilly and CompanyProstate Cancer

Start: 2008-03-31End: 2012-04-30Updated: 2019-04-03